Johnson & Johnson Says COVID Vaccine Lasts At Least 8 Months & Protects Against Delta Variant

BOSTON (CBS) - Johnson & Johnson says its vaccine is effective for at least eight months and protects against the Delta variant.

20 people in Boston were part of a small study conducted by doctors at Beth Israel Deaconess Medical Center and Harvard Medical School.

Doctors found the vaccine generates both a strong antibody response and creates immune cells known as T-Cells, which can help protect people longer from severe illness.

"The durability - the length of time these immune responses last - is really remarkable. We've tested eight months and there's really no evidence of decline over the eight-month period, so we do believe these responses will go on for a lot longer than that," said Dr. Dan Barouch, Director of the Center For Virology and Vaccine Research at Beth Israel.

A second study including people in Boston and across the country also found the vaccine is effective against a range of variants, including Delta and those first detected in South Africa and Brazil.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.